Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Daiichi Sankyo Sees 30% Growth for Edoxaban, Strong Enhertu Uptick in FY2019
April 28, 2020
- GSK, MICIN to Test Online Medical Exams and Medication Guidance for Improving Adherence in Asthma Patients
April 28, 2020
- Over 70% of Pharmacists Have “No Trouble” Getting Drug Info. Since Coronavirus Outbreak: Survey
April 28, 2020
- Keio Univ. Spinout Weighs In on AnGes' COVID-19 Vaccine Initiatives
April 28, 2020
- Shionogi Aims to Begin Clinical Studies for COVID-19 Vaccine in 2020
April 28, 2020
- Janssen Files for SC Injection of Darzalex/Vorhyaluronidase Alfa Combo for MM in Japan
April 28, 2020
- Novartis Japan Scraps Sales Offices to Boost Efficiency of Rep Activities
April 27, 2020
- AbbVie’s Rinvoq, MSD’s Noxafil Tablets Now Available
April 27, 2020
- Takeda Inks US$670 Million Divestment Deal for Europe OTC Biz
April 27, 2020
- Ohara Launches New Firm on Former Teva Takeda Site in Shiga Prefecture
April 27, 2020
- Sumitomo Dainippon, NIBIOHN Team Up on Universal Influenza Vaccine
April 27, 2020
- Fujifilm Commences Japan PI Study of Radioisotope Conjugate Antibody FF-21101
April 27, 2020
- Chugai’s Q1 Earnings Brisk on Hemlibra, Oncology Franchise
April 24, 2020
- Life Science Institute’s Muse Cell Product Shows Safety, Tolerability in 2 Trials
April 24, 2020
- Biogen Delays US Aducanumab Filing to Q3, but Keeps Japan’s 2020 Plan Intact
April 24, 2020
- CMIC Group to Support Clinical Trial, Manufacturing of Avigan for COVID-19 Treatment
April 24, 2020
- Kyorin’s Coronavirus Detection Reagent Now Available
April 24, 2020
- Relugolix Combo Improves Endometriosis, Non-Menstrual Pelvic Pain in PIII: Myovant
April 24, 2020
- Gene Techno CEO Eyes Lucentis Biosimilar Launch in November 2021, Expects Share of “At Least 30%”
April 23, 2020
- World’s 1st Topical JAK Inhibitor to Hit Shelves on June 24: JT/Torii
April 23, 2020
ページ
More than a year after Dupixent (dupilumab) became the first antibody therapy approved for COPD in Japan, drug makers are…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…